Effects of a TRH analog (DN-1417) and TRH-T on the electroconvulsive threshold.
D000818:Animals; D000927:Anticonvulsants; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide / Q000494:pharmacology; D002408:Catheters, Indwelling; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004597:Electroshock; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000927:Anticonvulsants; D008781:Methyltyrosines; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; D005680:gamma-Aminobutyric Acid; D013973:Thyrotropin-Releasing Hormone; C029762:DN 1417; C031476:alpha-methyl-m-tyrosine; D004298:Dopamine